Howson & Howson’s Life Sciences IP practice group serves start-up ventures, universities, non-profits, and small through Fortune 500 companies.
Howson & Howson brings special strength and experience in the life sciences, including the biotechnology and pharmaceutical industries. Whether a company is well established and pursuing a new invention or product line, or is in the early stages of evaluating technology and developing its business, our team has extensive experience with assisting companies in overcoming IP challenges at all stages of development.
All professionals in our team are registered to practice before the United States Patent and Trademark Office. Our attorneys have bar admissions in a number of state and federal jurisdictions including the Court of Appeals for the Federal Circuit and the Supreme Court of the United States. Each practitioner brings a unique background by education, training, and practice, including degrees in chemistry, microbiology, biochemistry and molecular biology.
The group has helped protect:
- Peptide chemistry and peptide-based therapeutics
- Nanotechnology
- Small molecules
- Pharmaceutical processes and products
- Diagnostics
- Medicinal chemistry
- Agricultural compositions and products
- Gene delivery
- Vaccine compositions
- Viral and non-viral delivery systems
We provide a range of services directed to the intellectual property needs of companies focusing in these technologies.
Intellectual property law services include:
- Patent procurement (prosecution)
- Early stage patentability assessments
- Validity, infringement and freedom-to-operate opinions
- Due diligence inquiries
- Asset transfer
- Portfolio evaluation in connection with insuring of royalty streams, bankruptcies, and other transactions
- Trademark/service mark registrability
- Clearance opinions
- Foreign filing strategy and coordination/oversight
